UTHR - United Therapeutics Corp
IEX Last Trade
363.32
3.100 0.853%
Share volume: 448,117
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$360.22
3.10
0.86%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-02 | 2023-02-22 | 2023-05-03 | 2023-08-02 | 2023-11-01 | 2024-02-21 | 2024-05-01 | 2024-07-31 | |
| Cash flow financing | 7.000 M | 55.500 M | 48.600 M | 24.700 M | 7.600 M | -92.800 M | -1.068 B | -48.000 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | 258.600 M | 128.200 M | 374.800 M | 106.300 M | 346.200 M | 150.700 M | 376.500 M | 232.200 M | |
| Net income | 239.300 M | 132.100 M | 240.900 M | 259.200 M | 267.600 M | 217.100 M | 306.600 M | 278.100 M | |
| Depreciation | 12.900 M | 13.200 M | 13.300 M | 12.900 M | 13.300 M | 13.700 M | 15.000 M | 18.700 M | |
| Changes in inventories | 91.000 M | 102.000 M | 102.500 M | 103.300 M | 104.300 M | 111.800 M | 120.200 M | 136.500 M | |
| Changes in receivables | 231.700 M | 220.400 M | 134.500 M | 272.700 M | 258.600 M | 278.900 M | 307.300 M | 290.700 M | |
| Investing Cashflow | -94.000 M | -189.300 M | -221.100 M | -227.200 M | -313.400 M | 42.100 M | 735.300 M | -80.000 M | |
| Net Borrowings | -1.934 B | -2.258 B | -2.156 B | -2.037 B | -2.296 B | -2.460 B | -2.221 B | -2.692 B | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -68.800 M | -39.500 M | -41.300 M | -44.700 M | -65.700 M | -78.700 M | -38.200 M | -45.100 M | |
| Cash Change | 2.616 B | 2.839 B | 2.863 B | 2.679 B | 2.876 B | 2.994 B | 2.708 B | 2.972 B |